According to GuruFocus Insider Data, the largest CFO sells during the past week were: Seattle Genetics Inc., Profire Energy Inc., Marriott International Inc, Express Scripts Holdings Company, Lionbridge Technologies Inc. and Repligen Corporation.
Seattle Genetics Inc. (SGEN, Financial): CFO Todd E. Simpson Sold 95,000 Shares
CFO Todd E. Simpson sold 95,000 shares of SGEN stock on 09/06/2012 at the average price of $28.5. Todd E. Simpson owns at least 70,762 shares after this. The price of the stock has increased by 1.37% since.
Seattle Genetic develops monoclonal antibody-based drugs to treat cancer and related diseases. Seattle Genetics Inc. has a market cap of $3.11 billion; its shares were traded at around $28.89 with and P/S ratio of 32.8. Seattle Genetics Inc. had an annual average earnings growth of 3.2% over the past 10 years. GuruFocus rated Seattle Genetics Inc. the business predictability rank of 3-star.
President and CEO Clay B. Siegall sold 8,250 shares of SGEN stock on 09/04/2012 at the average price of $26.54.
Profire Energy Inc. (PFIE, Financial): CFO Andrew Limpert Sold 80,000 Shares
CFO Andrew Limpert sold 80,000 shares of PFIE stock on 09/04/2012 at the average price of $1. Andrew Limpert owns at least 3,808,085 shares after this.
Profire Energy Inc. manufactures, installs and services oilfield combustion management systems and related burner products. Profire Energy Inc. has a market cap of $61.2 million; its shares were traded at around $1.35 with and P/S ratio of 3.8.
Profire Energy Inc. has released its 2013 fiscal results ended June 30, 2012. The company reported revenues of $3.67 million in this quarter, a 37% increase over the comparable quarter last year. EPS was $0.01, compared to $0.02 prior year quarter.
Marriott International Inc. (MAR, Financial): Executive Vice President and CFO Carl T. Berquist Sold 75,000 Shares
Executive Vice President and CFO Carl T. Berquist sold 75,000 shares of MAR stock on 09/06/2012 at the average price of $38.74. Carl T. Berquist owns at least 99,310 shares after this. The price of the stock has increased by 1.6% since.
Marriott International Inc. operates and franchises hotels under the Marriott, JW Marriott, The Ritz-Carlton, Renaissance, Residence Inn, Courtyard, TownePlace Suites, Fairfield Inn, SpringHill Suites and Ramada International brand names; develops and operates vacation ownership resorts under the Marriott Vacation Club International, Horizons, The Ritz-Carlton Club and Marriott Grand Residence Club brands; operates Marriott Executive Apartments; provides furnished corporate housing through its Marriott ExecuStay division; and operates conference centers. Marriott International Inc. has a market cap of $12.48 billion; its shares were traded at around $39.36 with a P/E ratio of 25.6 and P/S ratio of 1. The dividend yield of Marriott International, Inc. stocks is 1.4%.
Marriott International Inc. has released its second quarter 2012 results. Second quarter net income was $143 million, a 13% increase over prior year quarter. Diluted EPS increased 24% from the second quarter of 2011 to $0.42. EBITDA increased 13% to $289 million, and during this quarter, the company repurchased 10.5 million of its shares for $400 million.
President Americas Division David Grissen sold 45,200 shares of MAR stock on 09/06/2012 at the average price of $38.66.
Express Scripts Holding Company (ESRX, Financial): Executive Vice President and CFO Jeffrey Hall Sold 75,000 Shares
Executive Vice President and CFO Jeffrey Hall sold 75,000 shares of ESRX stock on 09/04/2012 at the average price of $62.81. Jeffrey Hall owns at least 78,357 shares after this. The price of the stock has increased by 0.76% since.
Express Scripts Inc. is one of the largest pharmacy benefit management companies in North America. Express Scripts Holding Company has a market cap of $50.35 billion; its shares were traded at around $63.29 with a P/E ratio of 19.5 and P/S ratio of 1.1. Express Scripts Holding Company had an annual average earnings growth of 25.9% over the past 10 years. GuruFocus rated Express Scripts Holding Company the business predictability rank of 5-star.
Express Scripts Holding Company has released its second quarter 2012 results. In this quarter, Express Scripts Holding generated gross profits of $2.2 billion – up 165% from prior year quarter. Gross profit margin increased to 7.8% from 7.1% in the second quarter of 2011, and EBITDA increased 132% from prior year quarter to $1.5 billion. Diluted EPS was $0.21 compared to $0.66 prior year quarter.
Lionbridge Technologies Inc. (LIOX, Financial): CFO Donald M. Muir Sold 173,134 Shares
CFO Donald M. Muir sold 173,134 shares of LIOX stock on 09/07/2012 at the average price of $3.73. Donald M. Muir owns at least 637,519 shares after this. The price of the stock has decreased by 10.46% since.
Lionbridge Technologies Inc. is a provider of globalization services to technology companies worldwide. Lionbridge Technologies Inc. has a market cap of $221 million; its shares were traded at around $3.34 with a P/E ratio of 11 and P/S ratio of 0.5.
Lionbridge Technologies Inc. reported second quarter 2012 revenue of $119.2 million, an increase of 5% over prior year quarter. GAAP net income was $2.5 million ($0.04 per share), compared to $1.7 million in the same quarter last year. Cash flow from operations in this quarter was $6.6 million.
Repligen Corporation (RGEN, Financial): CFO William J. Kelly Sold 95,000 Shares
CFO William J. Kelly sold 95,000 shares of RGEN stock on 08/31/2012 at the average price of $5.52. The price of the stock has decreased by 2.72% since.
Repligen Corporation develops new drugs based on naturally occurring peptides and proteins for autism, organ transplantation and immunesystem diseases. Repligen Corporation has a market cap of $175.5 million; its shares were traded at around $5.37 with a P/E ratio of 142.3 and P/S ratio of 6.4.
For the complete list of stocks that Sold by their CFOs, go to: Insider Buys.
Seattle Genetics Inc. (SGEN, Financial): CFO Todd E. Simpson Sold 95,000 Shares
CFO Todd E. Simpson sold 95,000 shares of SGEN stock on 09/06/2012 at the average price of $28.5. Todd E. Simpson owns at least 70,762 shares after this. The price of the stock has increased by 1.37% since.
Seattle Genetic develops monoclonal antibody-based drugs to treat cancer and related diseases. Seattle Genetics Inc. has a market cap of $3.11 billion; its shares were traded at around $28.89 with and P/S ratio of 32.8. Seattle Genetics Inc. had an annual average earnings growth of 3.2% over the past 10 years. GuruFocus rated Seattle Genetics Inc. the business predictability rank of 3-star.
President and CEO Clay B. Siegall sold 8,250 shares of SGEN stock on 09/04/2012 at the average price of $26.54.
Profire Energy Inc. (PFIE, Financial): CFO Andrew Limpert Sold 80,000 Shares
CFO Andrew Limpert sold 80,000 shares of PFIE stock on 09/04/2012 at the average price of $1. Andrew Limpert owns at least 3,808,085 shares after this.
Profire Energy Inc. manufactures, installs and services oilfield combustion management systems and related burner products. Profire Energy Inc. has a market cap of $61.2 million; its shares were traded at around $1.35 with and P/S ratio of 3.8.
Profire Energy Inc. has released its 2013 fiscal results ended June 30, 2012. The company reported revenues of $3.67 million in this quarter, a 37% increase over the comparable quarter last year. EPS was $0.01, compared to $0.02 prior year quarter.
Marriott International Inc. (MAR, Financial): Executive Vice President and CFO Carl T. Berquist Sold 75,000 Shares
Executive Vice President and CFO Carl T. Berquist sold 75,000 shares of MAR stock on 09/06/2012 at the average price of $38.74. Carl T. Berquist owns at least 99,310 shares after this. The price of the stock has increased by 1.6% since.
Marriott International Inc. operates and franchises hotels under the Marriott, JW Marriott, The Ritz-Carlton, Renaissance, Residence Inn, Courtyard, TownePlace Suites, Fairfield Inn, SpringHill Suites and Ramada International brand names; develops and operates vacation ownership resorts under the Marriott Vacation Club International, Horizons, The Ritz-Carlton Club and Marriott Grand Residence Club brands; operates Marriott Executive Apartments; provides furnished corporate housing through its Marriott ExecuStay division; and operates conference centers. Marriott International Inc. has a market cap of $12.48 billion; its shares were traded at around $39.36 with a P/E ratio of 25.6 and P/S ratio of 1. The dividend yield of Marriott International, Inc. stocks is 1.4%.
Marriott International Inc. has released its second quarter 2012 results. Second quarter net income was $143 million, a 13% increase over prior year quarter. Diluted EPS increased 24% from the second quarter of 2011 to $0.42. EBITDA increased 13% to $289 million, and during this quarter, the company repurchased 10.5 million of its shares for $400 million.
President Americas Division David Grissen sold 45,200 shares of MAR stock on 09/06/2012 at the average price of $38.66.
Express Scripts Holding Company (ESRX, Financial): Executive Vice President and CFO Jeffrey Hall Sold 75,000 Shares
Executive Vice President and CFO Jeffrey Hall sold 75,000 shares of ESRX stock on 09/04/2012 at the average price of $62.81. Jeffrey Hall owns at least 78,357 shares after this. The price of the stock has increased by 0.76% since.
Express Scripts Inc. is one of the largest pharmacy benefit management companies in North America. Express Scripts Holding Company has a market cap of $50.35 billion; its shares were traded at around $63.29 with a P/E ratio of 19.5 and P/S ratio of 1.1. Express Scripts Holding Company had an annual average earnings growth of 25.9% over the past 10 years. GuruFocus rated Express Scripts Holding Company the business predictability rank of 5-star.
Express Scripts Holding Company has released its second quarter 2012 results. In this quarter, Express Scripts Holding generated gross profits of $2.2 billion – up 165% from prior year quarter. Gross profit margin increased to 7.8% from 7.1% in the second quarter of 2011, and EBITDA increased 132% from prior year quarter to $1.5 billion. Diluted EPS was $0.21 compared to $0.66 prior year quarter.
Lionbridge Technologies Inc. (LIOX, Financial): CFO Donald M. Muir Sold 173,134 Shares
CFO Donald M. Muir sold 173,134 shares of LIOX stock on 09/07/2012 at the average price of $3.73. Donald M. Muir owns at least 637,519 shares after this. The price of the stock has decreased by 10.46% since.
Lionbridge Technologies Inc. is a provider of globalization services to technology companies worldwide. Lionbridge Technologies Inc. has a market cap of $221 million; its shares were traded at around $3.34 with a P/E ratio of 11 and P/S ratio of 0.5.
Lionbridge Technologies Inc. reported second quarter 2012 revenue of $119.2 million, an increase of 5% over prior year quarter. GAAP net income was $2.5 million ($0.04 per share), compared to $1.7 million in the same quarter last year. Cash flow from operations in this quarter was $6.6 million.
Repligen Corporation (RGEN, Financial): CFO William J. Kelly Sold 95,000 Shares
CFO William J. Kelly sold 95,000 shares of RGEN stock on 08/31/2012 at the average price of $5.52. The price of the stock has decreased by 2.72% since.
Repligen Corporation develops new drugs based on naturally occurring peptides and proteins for autism, organ transplantation and immunesystem diseases. Repligen Corporation has a market cap of $175.5 million; its shares were traded at around $5.37 with a P/E ratio of 142.3 and P/S ratio of 6.4.
For the complete list of stocks that Sold by their CFOs, go to: Insider Buys.
